Epivir, Epivir-hbv, Zeffix (lamivudine) is a small molecule pharmaceutical. Lamivudine was first approved as Epivir on 1995-11-17. It is used to treat acquired immunodeficiency syndrome, hepatitis b, and HIV infections in the USA. It has been approved in Europe to treat chronic hepatitis b and HIV infections.
|Trade Name||Epivir, Zeffix|
|Indication||acquired immunodeficiency syndrome, chronic hepatitis b, hepatitis b, hiv infections|
|Drug Class||Antineoplastics,antivirals (zidovudine group) (exception: edoxudine)|